AU2003265240A1 - Protease inhibitors - Google Patents
Protease inhibitorsInfo
- Publication number
- AU2003265240A1 AU2003265240A1 AU2003265240A AU2003265240A AU2003265240A1 AU 2003265240 A1 AU2003265240 A1 AU 2003265240A1 AU 2003265240 A AU2003265240 A AU 2003265240A AU 2003265240 A AU2003265240 A AU 2003265240A AU 2003265240 A1 AU2003265240 A1 AU 2003265240A1
- Authority
- AU
- Australia
- Prior art keywords
- protease inhibitors
- protease
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38288502P | 2002-05-22 | 2002-05-22 | |
US60/382,885 | 2002-05-22 | ||
PCT/US2003/016046 WO2003103574A2 (en) | 2002-05-22 | 2003-05-21 | Protease inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003265240A1 true AU2003265240A1 (en) | 2003-12-22 |
AU2003265240A8 AU2003265240A8 (en) | 2003-12-22 |
Family
ID=29736085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003265240A Abandoned AU2003265240A1 (en) | 2002-05-22 | 2003-05-21 | Protease inhibitors |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1511492A2 (en) |
AU (1) | AU2003265240A1 (en) |
WO (1) | WO2003103574A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA005893B1 (en) | 2000-03-21 | 2005-06-30 | Смитклайн Бичам Корпорейшн | Protease inhibitors |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT408396B (en) * | 1998-12-21 | 2001-11-26 | Ericsson Austria Ag | METHOD FOR TRANSMITTING DATA |
-
2003
- 2003-05-21 WO PCT/US2003/016046 patent/WO2003103574A2/en not_active Application Discontinuation
- 2003-05-21 AU AU2003265240A patent/AU2003265240A1/en not_active Abandoned
- 2003-05-21 EP EP03757275A patent/EP1511492A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2003103574A3 (en) | 2004-09-23 |
EP1511492A2 (en) | 2005-03-09 |
WO2003103574A2 (en) | 2003-12-18 |
AU2003265240A8 (en) | 2003-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003202263A1 (en) | Roh-kinase inhibitors | |
EP1499336A4 (en) | Protease inhibitors | |
AU2002305926A1 (en) | Cysteine protease inhibitors | |
EP1483254A4 (en) | Resistance-repellent retroviral protease inhibitors | |
AU2003249683A1 (en) | Nf-:b inhibitors | |
AU2003255952A1 (en) | Oxytocin inhibitors | |
AU2003249477A1 (en) | Heterobicylcic metalloproteinase inhibitors | |
AU2003277674A1 (en) | Novel parp inhibitors | |
AU2003234630A1 (en) | Cysteine protease inhibitors | |
EP1663279A4 (en) | Modified protease inhibitors | |
EP1704142A4 (en) | Protease inhibitors | |
AU2003230392A1 (en) | Beta-secretase inhibitors | |
AU2003256305A1 (en) | Peptidic compounds as cysteine protease inhibitors | |
AU2003269984A1 (en) | Protease inhibitors | |
AU2003299901A1 (en) | Thrombin inhibitors | |
AU2003295427A1 (en) | Flaviviris fusion inhibitors | |
AUPS282002A0 (en) | Metalloproteinase inhibitors | |
AU2002342682A1 (en) | Protease inhibitors | |
AU2003263738A1 (en) | Protease inhibitors | |
AU2003244347A1 (en) | Angiogenesis inhibitors | |
AU2003210671A1 (en) | Nek2 inhibitors | |
AU2003304496A1 (en) | Protease inhibitors | |
AU2003233642A1 (en) | Protease inhibitors | |
AU2003292406A1 (en) | Serine protease | |
AU2003287325A1 (en) | N-cycloalkylglycines as hiv protease inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |